Modi’s Jan Vishwas Bill gives the pharmaceutical industry a get-out-of-jail card
The Jan Vishwas Bill , which was recently passed by the Lok Sabha, has provoked a controversy regarding its implications for public health in India. This after the government put out a rather misleading press release in response to claims that one of us made on Twitter. Thread I am grateful that the @MoHFW_INDIA has issued a clarification to my tweet thread about the decriminalization of provisions of the Drugs and Cosmetics Act, 1940 which I re-posted yesterday after the Jan Vishwas Bill 2023 was passed in the Lok Sabha to rebut my 1/n — Dinesh S. Thakur (@d_s_thakur) July 28, 2023 Simply put, the government press release seeks to perpetuate its earlier claim that the bill aims to decriminalise only minor offences. This is simply not true because amendments pertaining to the Drugs and Cosmetics Act, 1940 goes to the core of drug quality. The act currently prescribes four different categories of offences pertaining to drug quality. These are adulterated drugs, spurious d